טוען...
Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis
BACKGROUND: Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD). We herein compare health outcomes associated with carvedilol or bisoprolol use, the most commonly prescribed BBs in these patients. METH...
שמור ב:
| הוצא לאור ב: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986334/ https://ncbi.nlm.nih.gov/pubmed/33779636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa248 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|